-
Panthera and Rutherford Health launch innovative oncology clinical trial network with expertise across more than 40 types of cancer; access to patients from more than 170 referring oncologists; state-of-the-art cancer treatment and diagnostic centres
Jun 24, 2020
-
Non-human primates are an important medium to understand laws of the organic world. Focusing on preclinical animal research for more than 10 years, Creative Biolabs provides a full range of NHP biological products to clients worldwide.
Jun 5, 2020
-
QuantuMDx Group today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within the European Union.
Jun 7, 2020
-
A ready-to-use, liquid stable Microprotein Standard Kit intended for the calibration or calibration verification, of total protein and albumin concentrations in both urine and cerebral spinal fluid (CFS), is now available from VERICHEM LABORATORIES.
Jun 7, 2020
-
Sugar based technology offers diagnosis on the spot in under 15 minutes
Jun 8, 2020
-
Jun 16, 2020
-
Chris Dodd has been appointed as the new Executive VP of Business Development – Oncology and CNS at Panthera Biopartners, an Independent Site Management Organisation based in Preston.
Jun 16, 2020
-
AMP releases preliminary results of its April 2020 SARS-CoV-2 testing survey for clinical laboratories.
May 27, 2020
-
May 28, 2020
-
May 28, 2020
-
May 27, 2020
-
Accumen’s team of laboratory experts has built a six-component, customizable program to help hospital and health system labs prepare for future pandemic or crisis situations.
May 28, 2020
-
Cutting-edge instrument platform and a novel host-immune response signature test rapidly distinguish between viral and bacterial infections to improve patient outcomes
Jun 1, 2020
-
Ubiquitome has signed an exclusive agreement for Swiss headquartered DKSH to market and sell its mobile, battery powered COVID-19 tester, Liberty16, in several Asia Pacific countries.
The agreement comes on the back of Ubiquitome recently receiving just over half a million dollars in New Zealand Government funding to help with increasing the manufacturing capacity for the Liberty16.
May 17, 2020
-
Bio-Rad Laboratories, Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19. The FDA listing extends access to the instrument to assay developers and testing laboratories in the U.S.
May 17, 2020
-
To facilitate global research about drugs or vaccines for COVID-19, Creative Biolabs has launched a series of antiviral drug discovery services for SARS-CoV-2, including High-Throughput Screening and Antiviral Agents Discovery.
May 18, 2020
-
May 19, 2020
-
May 20, 2020
-
May 20, 2020
-
May 20, 2020